New Zealand markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.23+0.13 (+2.13%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
29,962
33,215
34,505
28,267
32,100
Operating expenses
Research development
113,985
90,570
80,141
95,955
89,455
Selling general and administrative
47,338
30,775
24,748
32,596
34,040
Total operating expenses
161,323
121,345
104,889
128,551
123,495
Operating income or loss
-131,361
-88,130
-70,384
-100,284
-91,395
Interest expense
2,917
2,924
502
-
-
Total other income/expenses net
-557
981
-426
170
425
Income before tax
-132,327
-89,127
-70,279
-98,942
-89,380
Income from continuing operations
-132,327
-89,127
-70,279
-98,942
-89,380
Net income
-132,327
-89,127
-70,279
-98,942
-89,380
Net income available to common shareholders
-132,327
-89,127
-70,279
-98,942
-89,380
Basic EPS
-
-1.12
-1.24
-2.43
-2.21
Diluted EPS
-
-1.12
-1.24
-2.43
-2.21
Basic average shares
-
79,789
56,649
40,743
40,449
Diluted average shares
-
79,789
56,649
40,743
40,449
EBITDA
-
-79,625
-62,174
-92,422
-84,136